tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market

Silexion Therapeutics (SLXN) Balance Sheet

Compare
138 Followers

Silexion Therapeutics Balance Sheet

Silexion Therapeutics's total assets for Q3 2024 were $3.09M, an increase of 22.26% from the previous quarter. SLXN total liabilities were $7.67M for the fiscal quarter, a -56.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22
Total Assets
$ 5.26M$ 9.33M
Total Liabilities
$ 17.31M$ 16.41M
Total Equity Gross Minority
$ -12.06M$ -7.08M
Other Metrics
Currency in USD

Silexion Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis